• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自RANTES的N端截短合成肽片段类似物可抑制HIV-1感染性。

Analogues of N-terminal truncated synthetic peptide fragments derived from RANTES inhibit HIV-1 infectivity.

作者信息

Ramnarine Emabelle J, Devico Anthony L, Vigil-Cruz Sandra C

机构信息

Department of Pharmaceutical Sciences, University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269, USA.

出版信息

Bioorg Med Chem Lett. 2006 Jan 1;16(1):93-5. doi: 10.1016/j.bmcl.2005.09.044. Epub 2005 Oct 19.

DOI:10.1016/j.bmcl.2005.09.044
PMID:16236501
Abstract

A series of synthetic peptide fragments derived from RANTES were designed, synthesized, and evaluated to determine the effect of N-terminal truncation on the ability of the lead compound Ac[Ala(10,11)]RANTES-(1-14)NH(2) to inhibit HIV-1 infectivity. Both the lead compound and the truncated analogue Ac[Ala(10,11)]RANTES-(3-14)NH(2) were able to significantly inhibit HIV-1 infectivity. These results suggest that a small synthetic peptide may be able to mimic RANTES and have the ability to prevent transmission of HIV-1.

摘要

设计、合成并评估了一系列源自RANTES的合成肽片段,以确定N端截短对先导化合物Ac[Ala(10,11)]RANTES-(1-14)NH₂抑制HIV-1感染性能力的影响。先导化合物和截短类似物Ac[Ala(10,11)]RANTES-(3-14)NH₂均能够显著抑制HIV-1感染性。这些结果表明,一种小的合成肽可能能够模拟RANTES并具有预防HIV-1传播的能力。

相似文献

1
Analogues of N-terminal truncated synthetic peptide fragments derived from RANTES inhibit HIV-1 infectivity.源自RANTES的N端截短合成肽片段类似物可抑制HIV-1感染性。
Bioorg Med Chem Lett. 2006 Jan 1;16(1):93-5. doi: 10.1016/j.bmcl.2005.09.044. Epub 2005 Oct 19.
2
Synthetic full-length and truncated RANTES inhibit HIV-1 infection of primary macrophages.合成的全长和截短型RANTES可抑制HIV-1对原代巨噬细胞的感染。
AIDS. 1998 Jun 18;12(9):977-84.
3
Low-molecular-weight anti-HIV-1 peptides from the amino-terminal sequence of RANTES: possible lead compounds for coreceptor-directed anti-HIV-1 agents.来自RANTES氨基末端序列的低分子量抗HIV-1肽:共受体导向抗HIV-1药物的潜在先导化合物。
Bioorg Med Chem Lett. 1999 May 17;9(10):1357-60. doi: 10.1016/s0960-894x(99)00204-8.
4
Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES.RANTES中CCR5识别及HIV-1阻断的结构决定因素
Nat Struct Biol. 2001 Jul;8(7):611-5. doi: 10.1038/89653.
5
Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4.高效HIV抑制:将PSC-RANTES中的关键抗HIV结构改造至MIP-1β/CCL4中。
Protein Eng Des Sel. 2008 Feb;21(2):65-72. doi: 10.1093/protein/gzm079. Epub 2008 Jan 4.
6
Anti-HIV-1 peptides derived from partial amino acid sequences of CC-chemokine RANTES. Regulated upon activation, normal T-cell expressed and secreted.源自CC趋化因子RANTES部分氨基酸序列的抗HIV-1肽。在激活时受到调节,由正常T细胞表达和分泌。
Bioorg Med Chem. 2002 Dec;10(12):4113-7. doi: 10.1016/s0968-0896(02)00271-7.
7
Semisynthetic analogues of PSC-RANTES, a potent anti-HIV protein.PSC-RANTES的半合成类似物,一种有效的抗HIV蛋白。
Bioconjug Chem. 2008 Feb;19(2):480-9. doi: 10.1021/bc7003044. Epub 2008 Jan 8.
8
Anti-HIV activity and conformational studies of peptides derived from the C-terminal sequence of SDF-1.源自SDF-1 C末端序列的肽的抗HIV活性及构象研究
J Med Chem. 2004 Jun 3;47(12):3058-64. doi: 10.1021/jm031067a.
9
Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides.通过RANTES衍生肽的热点进化增强抗HIV-1活性。
Chem Biol. 2012 Dec 21;19(12):1579-88. doi: 10.1016/j.chembiol.2012.10.007.
10
Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.新型X4型HIV-1进入抑制剂-L-和D-精氨酸肽-氨基糖苷缀合物的结构-功能关系
FEBS J. 2007 Dec;274(24):6523-36. doi: 10.1111/j.1742-4658.2007.06169.x. Epub 2007 Nov 20.

引用本文的文献

1
Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infections.利用肽的治疗、生物和自组装潜力治疗病毒感染。
J Control Release. 2022 Aug;348:1028-1049. doi: 10.1016/j.jconrel.2022.06.037. Epub 2022 Jul 6.
2
Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTES.强效抗 HIV 趋化因子变体 P2-RANTES 的结构与功能研究。
Proteins. 2010 Feb 1;78(2):295-308. doi: 10.1002/prot.22542.
3
Rational design of novel HIV-1 entry inhibitors by RANTES engineering.
通过RANTES工程进行新型HIV-1进入抑制剂的合理设计。
Vaccine. 2008 Jun 6;26(24):3008-15. doi: 10.1016/j.vaccine.2007.12.023. Epub 2008 Jan 10.